Diagnosis of melanoma under concomitant natalizumab therapy

Mult Scler. 2011 Feb;17(2):255-6. doi: 10.1177/1352458510389629. Epub 2010 Dec 21.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Drug Administration Schedule
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / adverse effects*
  • Melanoma / diagnosis*
  • Melanoma / etiology
  • Melanoma / pathology
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Risk Factors
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / etiology
  • Skin Neoplasms / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Natalizumab